Susquehanna International Group
FBRX icon

Susquehanna International Group’s Forte Biosciences FBRX Stock Holding History

Susquehanna International Group’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.46M Buy
133,494
+80,580
+152% +$2.32M ﹤0.01% 4977
2025
Q4 		$1.44M Buy
+52,914
New +$928K ﹤0.01% 6350
2024
Q4 		– Sell
-13,096
Closed -$73.3K – 12485
2024
Q3 		$73.3K Buy
13,096
+11,722
+853% +$121K ﹤0.01% 11211
2024
Q2 		$18.4K Buy
+1,374
New +$22.2K ﹤0.01% 11681
2023
Q3 		– Sell
-1,213
Closed -$31.5K – 12271
2023
Q2 		$31.5K Buy
1,213
+800
+194% +$20.8K ﹤0.01% 11498
2023
Q1 		$10.4K Sell
413
-124
-23% -$3.12K ﹤0.01% 12198
2022
Q4 		$13.4K Buy
+537
New +$13.8K ﹤0.01% 11875
2022
Q3 		– Sell
-4,709
Closed -$153K – 13440
2022
Q2 		$153K Buy
4,709
+3,608
+328% +$115K ﹤0.01% 10996
2022
Q1 		$40K Sell
1,101
-1,743
-61% -$66K ﹤0.01% 12401
2021
Q4 		$152K Sell
2,844
-6,125
-68% -$412K ﹤0.01% 11774
2021
Q3 		$664K Buy
+8,969
New +$4.97M ﹤0.01% 8650
2021
Q2 		– Sell
-2,102
Closed -$1.8M – 12742
2021
Q1 		$1.8M Buy
+2,102
New +$1.72M ﹤0.01% 6177
2020
Q4 		– Sell
-180
Closed -$219K – 11190
2020
Q3 		$219K Buy
+180
New +$119K ﹤0.01% 9308
2019
Q4 		– Sell
-170
Closed -$38.5K – 9946
2019
Q3 		$42K Buy
170
+124
+270% +$188K ﹤0.01% 9829
2019
Q2 		$114K Buy
+46
New +$136K ﹤0.01% 9544
2019
Q1 		– Sell
-71
Closed -$274K – 9118
2018
Q4 		$220K Buy
+71
New +$306K ﹤0.01% 7564
2018
Q2 		– Sell
-38
Closed -$139K – 9820
2018
Q1 		$170K Buy
+38
New +$176K ﹤0.01% 8447

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Susquehanna International Group's FBRX Position: Q1 2026 in Review

Susquehanna International Group increased its Forte Biosciences (FBRX) stake by 152% in Q1 2026, buying an estimated $2.32M and bringing the position to 133,494 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #4977.

Susquehanna International Group first reported a position in FBRX in Q1 2018 and has held it in 17 quarters since. 68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

  • Susquehanna International Group held 133,494 shares of Forte Biosciences worth $3.46M as of Q1 2026.
  • Susquehanna International Group bought 80,580 Forte Biosciences shares in Q1 2026, an estimated $2.32M.
  • Forte Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4977 holding.
  • Susquehanna International Group first reported a position in Forte Biosciences in Q1 2018 and has held it in 17 quarters since.
  • 68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.